|
|
RNAi Therapeutics 2008 Market Report
Published: November 2007
Pages: 171
This is the latest RNAi-based Therapeutics Market Report from Select Biosciences. This report presents an up-to-date thorough analysis of the RNAi therapeutics landscape based upon our continuing coverage of this dynamic marketplace. This report presents an exhaustive analysis of all the therapeutics areas where research efforts using RNAi-based therapeutics are being focused: From Research/Pre-Clinical through Phase III Clinical Trials. Select Biosciences proprietary market survey addresses druggability trends, drug target classes (where RNAi therapeutics will impact) and different therapeutic areas in terms of challenges/opportunities/quantitative industry metrics—this highly valuable dataset is based on an extensive market analysis.
An extensive analysis of the Intellectual Property (IP) landscape in RNAi therapeutics space, RNAi technology trends, and relevant company profiles make this report a complete and timely industry analysis.
Report Table of Contents [Downloadable PDF File]
Sample Pages from the Market Report [Downloadable PDF File]
For more details about the industry coverage/specific topics that are presented in this report, e-mail us at KGray@Selectbiosciences.com.
Topics Covered in this ReportOpportunities and challenges in the RNAi therapeutics spaceTherapeutics areas impacted by RNAi therapeutics: Timeline for impact, top-most challenge in each therapeutic areaDifferent target classes and their amenability to targeting using RNAi therapeuticsTop-most drug target class for RNAi therapeuticsDelivery approach by therapeutic areaFactors that determine whether a given target will be druggable via RNAi-based therapeuticsOpportunities for vendors in the spaceResearch/Pre-Clinical, Phase I, Phase II, and Phase III RNAi therapeutics Clinical Trials: Details by company, molecular target, therapeutic/disease area, partnership[s]Technology trends in the RNAi spaceIntellectual property (IP) in the RNAi therapeutics space: Landscape and discussion of the various key patentsRelevant company profiles: Partnerships, therapeutics/trials pipeline
Purchase report >>
|
|
|